Quick Enquire
Eliglustat intermediates manufacturers

Eliglustat intermediates manufacturers

A.R. Life Sciences are high-quality Eliglustat intermediates manufacturers, all our intermediates are manufactured by following ICH standards. We are committed to delivering high-grade products. We have a distinct research and development department constantly working on the best formulations which can be brought into the market at the best prices. We offer standard and customized packages as well depending on our customer requirement. Our products are not merely of high quality but are also formulated following stringent guidelines. We have personnel assigned specifically for delivering products that meet GMP standards.
Eliglustat is used as an inhibitor of glucosylceramide synthase for the therapy of type 1 Gaucher disease. Eliglustat is proven to have been linked to serum enzyme elevations during therapy or during acute liver injury. We as Eliglustat intermediates manufacturers, develop intermediates in a powdered format, following standard guidelines in the industry. We accept orders of a minimum quantity of 100gms.

Eliglustat is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease. Clinical experience with eliglustat is limited, but it not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.




  • Product Features
  • Advantages
  • Applications
  • Specifications
  • Form: Powder
  • Minimum order quantity: 100gram
  • Categories: Pharma intermediates, Pharma API, Pharmaceutical intermediates, Pharmaceutical API, Active Pharmaceutical Ingredients
  • Usage/Application: Commercial
  • Manufacturer: A. R. Life sciences Pvt Ltd.
  • Cancer (Bendamustine intermediates, Imatinib intermediates)
  • Cardiovascular (Clopidogrel bisulphate intermediate & API)
  • Anti-Coagulant (Dabigatran intermediates & API, CamostatMesylate intermediates & API)
  • Leukemia (Dasatinib intermediates)
  • Pain (Elagolix intermediate)
  • Gaucher disease (Eliglustat intermediates)
  • Osteoporosis (Ibandronate intermediate)
  • Cystic fibrosis (Ivacaftor intermediates)
  • Hyperuricemia (Lesinurad intermediate)
  • Urinary Incontinence (Mirabegron, Solifenacin intermediates)
  • Nausea & vomiting (Ondansetron intermediates)
  • Anti-Psychotic (Paliperidone/Risperidone, Quetiapine intermediates)
  • Acute Diarrhoea (Racecadotril intermediates)
  • Deep vein thrombosis (Rivaroxaban intermediate)
  • Type 2 Diabetes (Sitagliptin intermediates)
  • NSAID (Etodolac API)
  • Antibiotic (Sparfloxacin API)
  • Anti-Arrhythmic agent (Adenosine API)
  • Anti-Lipemic (Rosuvastatin calcium API)
  • Iron chelator (Deferasirox)
  • Purity, Grade

Eliglustat Intermediates Specifications:

Intermediate CAS No API/End Use Status Purity
2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde 29668-44-8 Eliglustat Commercial
S(+)-2-Phenylglycinol 20989-17-7 Eliglustat Commercial 99.96%